Sartorius Stedim Biotech Aktie
203,20
EUR
-2,00
EUR
-0,97
%
203,60
EUR
-2,90
EUR
-1,40
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
21.02.25 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
30.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
30.01.25 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
29.01.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
09.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
07.01.25 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
17.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
03.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
Werbung
|
|||
02.09.24 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
12.03.24 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
29.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
06.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
20.06.23 | Sartorius Stedim Biotech Buy | UBS AG | |
19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
07.03.23 | Sartorius Stedim Biotech Buy | HSBC | |
22.07.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
04.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
22.04.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. |
Werbung
Werbung